Cargando…

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival

PURPOSE: Previous studies demonstrate that threonine and tyrosine kinase (TTK) is overexpressed in triple-negative breast cancer (TNBC), but there are conflicting results regarding its effect on TNBC survival. The purpose of this study was to assess the prognostic significance of TTK expression in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qianqian, Xu, Yali, Pan, Bo, Wu, Liangcai, Ren, Xinyu, Zhou, Yidong, Mao, Feng, Lin, Yan, Guan, Jinghong, Shen, Songjie, Zhang, Xiaohui, Wang, Changjun, Zhong, Ying, Zhou, Liangrui, Liang, Zhiyong, Zhao, Haitao, Sun, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348432/ https://www.ncbi.nlm.nih.gov/pubmed/27833085 http://dx.doi.org/10.18632/oncotarget.13245

Ejemplares similares

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer
por: Song, Yu, et al.
Publicado: (2020)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
por: Zhong, Ying, et al.
Publicado: (2022)

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
por: Shen, Songjie, et al.
Publicado: (2014)

lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression
por: Zhang, Xiaohui, et al.
Publicado: (2020)

Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
por: Zhong, Ying, et al.
Publicado: (2023)

Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial
por: Shen, Songjie, et al.
Publicado: (2017)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer
por: King, Jamie L., et al.
Publicado: (2018)

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
por: Li, Yan, et al.
Publicado: (2020)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
por: Zhong, Ying, et al.
Publicado: (2016)

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation
por: Zhong, Ying, et al.
Publicado: (2020)

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)

Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial
por: Wang, Changjun, et al.
Publicado: (2020)

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series
por: Zhong, Ying, et al.
Publicado: (2019)

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
por: Zhong, Ying, et al.
Publicado: (2013)

Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction
por: Wang, Changjun, et al.
Publicado: (2022)

Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer
por: Ren, Xinyu, et al.
Publicado: (2022)

The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer
por: Li, Yan, et al.
Publicado: (2019)

Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis
por: Shen, Songjie, et al.
Publicado: (2021)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA)
por: Wang, Changjun, et al.
Publicado: (2022)

Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?
por: Wang, Changjun, et al.
Publicado: (2018)

Breast-conserving surgery without axillary surgery and radiation versus mastectomy plus axillary dissection in elderly breast cancer patients: A retrospective study
por: Zhong, Ying, et al.
Publicado: (2023)

Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy
por: Zhou, Yidong, et al.
Publicado: (2016)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial
por: Pei, Lijian, et al.
Publicado: (2015)

Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017)
por: Pan, Bo, et al.
Publicado: (2022)

Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study
por: Lin, Yan, et al.
Publicado: (2017)

Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2016)

Expression and function of MutT homolog 1 in distinct subtypes of breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2017)

CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer
por: Lee, Cheng-Chin, et al.
Publicado: (2023)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
por: Liu, Yixuan, et al.
Publicado: (2021)

A nomogram for individually predicting overall survival for elderly patients with early breast cancer: a consecutive cohort study
por: Zhong, Ying, et al.
Publicado: (2023)

The Diagnostic Performance of Minimally Invasive Biopsy in Predicting Breast Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2020)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer
por: Miao, Ruoyu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ebgb5cl7b2279o0etfmph92mek